Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Chronic Kidney Disease Companies

ID: MRFR/Pharma/4289-HCR
110 Pages
Vikita Thakur
Last Updated: February 16, 2025
Chronic Kidney Disease companies are at the forefront of combating this widespread health challenge. Through research, development, and distribution of advanced medical solutions, they contribute significantly to the management and treatment of chronic kidney diseases, improving patient outcomes worldwide.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Chronic Kidney Disease Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)5.78%
2024 Market Size$ 40.53 Billion
2025 Market Size$ 42.87 Billion
2035 Market Size$ 75.22 Billion

Key Players

Companies such as Fresenius Medical Care
DaVita Inc.
Baxter International Inc.
Abbott Laboratories
Amgen Inc.
Eli Lilly and Company
Opportunities
  • Government Initiatives and Funding
  • Increased Focus on Preventive Healthcare
  • Advancements in Renal Replacement Therapies

Top Industry Leaders in the Chronic Kidney Disease Market

Chronic Kidney Disease Market
ย 

Latestย Chronic Kidney Diseaseย Companiesย Updates:

Ardelyx Receives FDA Approval for Xphozah (fosdenopterin): This drug treats hyperphosphatemia, a common complication in CKD patients, offering a new treatment option and potentially improving patient outcomes.

Bayer Introduces Kerendia (finerenone) in India: This drug, touted as a potential blockbuster for CKD, is the first SGLT2 inhibitor specifically approved for CKD. Its introduction in a major market like India expands access and treatment options for patients.

Roche and Genmab Partner on Novel Kidney Disease Treatment: The collaboration aims to develop a drug targeting a specific protein involved in CKD progression, offering a potential breakthrough therapy.

List of Chronic Kidney Disease companies in the market:

  • Abbott (US)

  • Siemens (Germany)

  • Beckman Coulter (US)

  • F. Hoffmann-La Roche Ltd (Switzerland)

  • ACON Laboratories, Inc (US)

  • Nova Biomedical (US)

  • ARKRAY (Japan)

  • AstraZenecaย (UK)

  • GlaxoSmithKline Plc (UK)

  • Bayer AG (Germany)